- Title
- LBA01-07 OVERALL SAFETY AND INCIDENCES OF ADVERSE EVENTS BY TIME INTERVAL WITH DAROLUTAMIDE PLUS ANDROGEN-DEPRIVATION THERAPY AND DOCETAXEL IN THE PHASE 3 ARASENS TRIAL
- Creators
- E. David CrawfordMatthew R. SmithBertrand TombalKarim FizaziMaha HussainCora N. SternbergArash Rezazadeh KalebastyRonald TutroneNeal D. ShoreLaurence BelkoffSilke ThieleRui LiIris KussHeikki JoensuuFred Saad
- Publication Details
- The Journal of urology, v 207(Supplement 5)
- Publisher
- Lippincott
- Resource Type
- Abstract
- Language
- English
- Academic Unit
- Surgery
- Other Identifier
- 991021916911804721
Abstract
LBA01-07 OVERALL SAFETY AND INCIDENCES OF ADVERSE EVENTS BY TIME INTERVAL WITH DAROLUTAMIDE PLUS ANDROGEN-DEPRIVATION THERAPY AND DOCETAXEL IN THE PHASE 3 ARASENS TRIAL
The Journal of urology, v 207(Supplement 5)
May 2022
Metrics
5 Record Views